A newly identified COVID-19 variant, BA.3.2—nicknamed “Cicada”—is making waves across more than 23 countries, and health experts are keeping a close eye on its rapid spread and mutation profile.
The strain, a descendant of the Omicron BA.3 lineage, is drawing attention due to its unusual “comeback” nature—similar to cicadas that re-emerge after years underground. Scientists say this variant carries notable genetic differences from more recent strains like JN.1 and LP.8.1, which were used to develop current vaccines.
🧬 Early findings suggest:
• It may spread faster than earlier Omicron variants
• It has mutations that could reduce vaccine effectiveness against infection
• However, protection against severe illness still appears strong
According to global surveillance:
📍 First detected in South Africa (Nov 2024)
📍 Now present in 23+ countries
📍 Accounts for ~0.55% of U.S. cases
📍 Surging up to 30% in parts of Europe
Common symptoms remain familiar:
🤒 Fever
😷 Cough
🗣️ Sore throat (most reported)
😴 Fatigue
🤕 Headache
👃 Loss of taste or smell
Experts like Dr. Marc J. Kahn and Dr. Robert H. Hopkins Jr. emphasize that there is no current evidence the “Cicada” variant causes more severe illness.
💉 Bottom line:
Vaccines may be slightly less effective at preventing infection—but they still provide strong protection against hospitalization and death.
🛑 Stay alert, not alarmed:
Continue basic precautions, stay updated with vaccinations, and monitor guidance from health authorities.
Post a Comment